CARLSBAD, Calif., Feb. 20, 2014 /PRNewswire/ -- Patriot Scientific Corporation (OTCBB: PTSC) today announced that the United States International Trade Commission (ITC) has issued a notice affirming the Administrative Law Judge's September 6, 2013 Initial Determination (ID) in regards to Patriot's US 5,809,336 ('336) patent. An Investigation had been undertaken by the ITC in which Patriot and other complainants alleged violations of Section 337 of the Tariff Act, seeking importation bans against multiple respondents for certain wireless consumer electronics devices marketed for sale in the United States. The ITC reaffirmed that it found no violation of Section 337 in the aforementioned investigation.
"We are disappointed the ITC has upheld its previous finding in regards to the '336 patent," stated Cliff Flowers, Patriot's Interim Chief Executive Officer. "Several of our shareholders question how our October 2013 victory against HTC in U.S. District Court for the Northern District of California over the same '336 patent, reconciles with the ITC's position. Simply stated, we believe the District Court got it right, and the ITC got it wrong. We are evaluating our options with the ITC."
Respondents who remained subject to the ITC Investigation included Barnes & Noble Inc., Garmin Ltd., HTC Corporation, Huawei Technologies Co. Ltd., LG Electronics, Nintendo Co. Ltd., Novatel Wireless Inc., Samsung Electronics Co. Ltd., and ZTE Corporation. Parallel proceedings in the U.S. District Court for the Northern District of California alleging infringement of Patriot's '749, '890 and '336 patents against the remaining ITC Respondents, excluding HTC, have been stayed pending resolution of the ITC Investigation.
In October, Patriot announced that it had won its patent infringement lawsuit against HTC Corporation in the U.S. District Court for the Northern District of California. HTC was found to infringe multiple claims of Patriot's '336 patent. The '336 patent is one of several patents that are part of a larger portfolio held by Patriot, known as the Moore Microprocessor Patent Portfolio(TM).
About Patriot Scientific Corporation
Headquartered in Carlsbad, California, Patriot Scientific Corporation is the co-owner of the Moore Microprocessor Patent Portfolio. For more information on PTSC, visit www.ptsc.com.
About the MMP Portfolio(TM)
The MMP Portfolio includes US patents as well as their European and Japanese counterparts, which cover techniques that enable higher performance and lower cost designs essential to consumer and commercial digital systems ranging from PCs, cell phones and portable music players to communications infrastructure, medical equipment and automobiles.
Safe Harbor Statement: Statements herein which are not purely historical, including statements regarding Patriot Scientific Corporation's intentions, hopes, beliefs, expectations, intentions, representations, projections, plans or predictions of the future are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The forward-looking statements involve risks and uncertainties including, but not limited to, the risk that the recently filed actions and litigation strategy may not be successful and the risks and uncertainties relating to the future of our MMP joint-venture. It is important to note that the company's actual results could differ materially from those in any such forward-looking statements. Factors that could cause actual results to differ materially include, but are not limited to, risks and uncertainties associated with the effect of changing economic conditions, trends in the products markets, variations in the company's cash flow, market acceptance risks, patent litigation, technical development risks, and seasonality. Our business could be affected by a number of other factors, including the risk factors listed from time to time in the company's SEC reports including, but not limited to, the annual report on Form 10-K for the year ended May 31, 2013 and the quarterly report on Form 10-Q for the period ended November 30, 2013. The company cautions investors not to place undue reliance on the forward-looking statements contained herein. Patriot Scientific Corporation disclaims any obligation, and does not undertake to update or revise any forward-looking statements made herein.
Patriot Investor Relations
SOURCE Patriot Scientific Corporation